May 16, 2022 04:01 PM
|No data found|
Tatva Chintan Pharma Chem Ltd was incorporated as `Tatva Chintan Pharma Chem Private Limited` pursuant to a certificate of incorporation dated June 12, 1996 issued by the Registrar of Companies, Gujarat and Dadra & Nagar Haveli at Ahmedabad ("RoC"). Thereafter, pursuant to the conversion of the Company to a public limited company, the name of our Company was changed to `Tatva Chintan Pharma Chem Limited`, and a fresh certificate of incorporation dated February 26, 2021 was issued to our Company by the RoC. The company is a specialty chemicals manufacturing company engaged in the manufacture of a diverse portfolio of structure directing agents ("SDAs"), phase transfer catalysts ("PTCs"), electrolyte salts for super capacitor batteries and pharmaceutical and agrochemical intermediates and other specialty chemicals ("PASC"). The company is the largest and only commercial manufacturer of SDAs for zeolites in India. It also enjoys the second largest position globally. In addition, the Company is one of the leading global producers of an entire range of PTCs in India and one of the key producers across the globe In 2004, the company received licence to manufacture for sale (or for distribution) of certain drugs from the Food and DrugsControl Administration, Gujarat at the Ankleshwar Manufacturing Facility In 2007, there was an expansion of manufacturing capacity at the companies Ankleshwar Manufacturing Facility In 2011, the company started commercial manufacturing of SDAs In 2015, 2017 and 2018, the company set up Warehousing facility in netherlands, set up Dahej manufacturing facility and set up R&D manufacturing facility in Vadodara respectively. In 2020, the company converted Ankleshwar Manufacturing Facility to a `zero liquid effluent discharge facility` and also during the year 2020 under review, there was a increase in manufacturing capacity at the companies Dahej Manufacturing Facility resulting in an increase in the aggregate manufacturing capacity of the Company from 160 KL and 10 Assembly Lines to 280 KL and 13 Assembly Lines.
|AGM Date (Month)||:||Oct|
|Face Value Equity Shares||:||10|
|Market Lot Equity Shares||:||1|
|Book Closure Date (Month)||:|